Brainstorm Cell TherapeuticsBCLI
13F holders, Q4 2024 (December 31)31holders +27
10new positions
1sold out
$1.29avg. 13F price*
At the end of Q4 2024, 31 institutions reported holding Brainstorm Cell Therapeutics (BCLI) in their 13F filings, up 27 from Q3 2024. 10 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($178K), Geode Capital Management, LLC ($119K) and BlackRock, Inc. ($57K).
- Company
- Brainstorm Cell Therapeutics
- CUSIP
- 10501E300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $64K |
| Exits | 1 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 207,880 shares bought and 34,228 shares sold, net +173,652 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Vanguard Group Inc. | 0.00% | Reduce -22.1% | 78,441 | $178K |
| Geode Capital Management, LLC | 0.00% | Add +15.3% | 52,501 | $119K |
| BlackRock, Inc. | 0.00% | No change | 25,172 | $57K |
| HRT Financial LP | 0.00% | New | 20,022 | $45K |
| Two Sigma Securities, LLC | 0.00% | Add +756.2% | 11,300 | $26K |
| Ikarian Capital, LLC | 0.00% | New | 6,016 | $14K |
| Morgan Stanley | 0.00% | Add +30.9% | 4,317 | $10K |
| UBS Group AG | 0.00% | Add +1982.4% | 3,472 | $8K |
| Citigroup Inc. | 0.00% | New | 1,971 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +173.1% | 1,915 | $4K |
| Wells Fargo & Company | 0.00% | Reduce -62.0% | 1,338 | $3K |
| Avior Wealth Management, LLC | 0.00% | Reduce -0.2% | 747 | $2K |
| Activest Wealth Management | 0.00% | No change | 334 | $758 |
| SBI Securities Co., Ltd. | 0.00% | — | 167 | $379 |
| Transce3nd, LLC | 0.00% | — | 148 | $336 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 141 | $320 |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -37.2% | 113 | $257 |
| FMR LLC | 0.00% | New | 111 | $252 |
| Bank of America Corp. | 0.00% | Reduce -1.1% | 106 | $241 |
| Clearstead Advisors, LLC | 0.00% | No change | 100 | $227 |
| Cranbrook Wealth Management, LLC | 0.00% | New | 66 | $150 |
| St Germain D J Co. Inc. | 0.00% | Reduce -1.0% | 33 | $75 |
| BNP Paribas Financial Markets | 0.00% | New | 24 | $54 |
| Centricity Wealth Management, LLC | 0.00% | — | 20 | $45 |
| CBIZ Investment Advisory Services, LLC | 0.00% | New | 13 | $30 |
| Westside Investment Management, Inc. | 0.00% | Reduce -10.0% | 12 | $28 |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -6.8% | 10 | $23 |
| CoreCap Advisors, LLC | 0.00% | New | 8 | $18 |
| JPMorgan Chase & Co. | 0.00% | Reduce -57.1% | 5 | $11 |
| Bogart Wealth, LLC | 0.00% | Reduce -11.8% | 2 | $5 |
| Caldwell Sutter Capital, Inc. | 0.00% | New | 157,009 | $0 |
"% of holder's portfolio" is BCLI's weight in each manager's 13F, not the share of Brainstorm Cell Therapeutics the manager owns.